This article reviews the changes in expression, mechanism of action, and clinical significance of Tim-3 in major respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), acute respiratory distress syndrome (ARDS), pulmonary infections, lung cancer, and pulmonary fibrosis. This evidence concerns the gene HAVCR2 and lung carcinoma.